Max Kevane-Campbell is a PhD student at the Department of Infectious Diseases and the Institute of Medical Microbiology and Infection Control, University Hospital Frankfurt. His research concentrates on resistance determinants, plasmid pathogenicity and phage therapy of non-tuberculous mycobacteria.